New Zealand Living Cell-Otsuka Partnership Implants Pig Cells Into Parkinson’s Patient: AusBiotech
This article was originally published in PharmAsia News
Executive Summary
New Zealand’s Living Cell Technologies has taken a key clinical step in regenerative and replacement branded cell therapy work focused on Parkinson’s disease and type 1 diabetes that has drawn investment from Japan’s Otsuka. The progress report was presented at the Australia Biotech Invest conference in Melbourne in late October.